ALGN Price Prediction Next Week
Technical Analysis:
Based on the latest data, ALGN shows bearish signals in the short term:
- RSI (14) at 37.73 indicates a neutral to slightly oversold condition
- MACD is negative at -3.76 with bearish divergence (MACD line below signal line)
- Stochastic (14,3,3) at 7.33 shows extremely oversold conditions
- Price is trading below all major moving averages (5,10,20,60,200,250 SMAs), indicating strong bearish momentum
Price Levels:
- Current price: $206.77
- Fibonacci resistance levels: R1: $226.78, R2: $233.91, R3: $245.45
- Fibonacci support levels: S1: $203.71, S2: $196.58, S3: $185.05
News Impact:
- Wells Fargo initiated coverage with Overweight rating and $255 price target on February 14, 2025
- Institutional ownership has decreased by 5.54% in recent quarter
- Put/call ratio of 1.51 indicates bearish sentiment from options traders
- Q4 earnings missed estimates with EPS of $2.44 vs expected $2.45
Price Prediction for Next Week: Based on technical indicators and recent news:
- Bearish scenario (60% probability): Price likely to test S1 at $203.71, potentially dropping to S2 at $196.58
- Neutral scenario (30% probability): Consolidation between $203-$207
- Bullish scenario (10% probability): Bounce from oversold conditions to $210-215
Recommendation: SELL
- Entry: Current price ($206.77)
- Target: $196.58 (S2 level)
- Stop loss: $210.50 (above recent resistance)
ALGN Similar Chart Price Prediction
The price of ALGN is predicted to go up -20.59%, based on the high correlation periods with EME. The similarity of these two price pattern on the periods is 96.01%.
ALGN
EME
Down: -20.59%Similarity: 96.01%
ALGN Revenue Forecast
ALGN EPS Forecast
ALGN FAQs
What is bull’s view on ALGN?
What is bear's view on ALGN?
What is ALGN revenue forecast for next quarter？
What is ALGN eps forecast for next quarter？
ALGN VS S&P500
Invisalign is likely to win over new doctors and patients as adoption of clear aligners increases and chips away at wire and bracket market share.
Invisalign can continue to expand its presence in the underpenetrated teen market, with more offerings and effective marketing strategy.
More dental and orthodontic offices are likely to purchase iTero scanners as they adopt digital solutions, and Align will benefit from higher sales as well as synergies created from the Exocad acquisition.
ALGN Analyst's Forecast
Vik Chopra
Wells Fargo
Buy
2025-02-14
Price Target
$255
Upside
+22.33%
Wells Fargo initiated coverage of Align Technology with an Overweight rating and $255 price target. As the market leader in clear aligners with two-thirds market share and strong brand recognition, Align has a "durable and competitive moat," the analyst tells investors in a research note. The firm believes the market is underpenetrated with 22M people out of a pool of 600M seeking treatment for malocclusion. It estimates Align's penetration is 10%-11%, leaving "significant runway for long-term, durable growth." With the stock trading at a 29% discount to its three-year average, Align shares "are poised to run when the market improves," contends Wells.
Erin Wright
Morgan Stanley
Buy
2025-02-06
Price Target
$280 → $272
Upside
+25.95%
Brandon Couillard
Jefferies
Strong Buy
2025-01-23
Price Target
$285 → $260
Upside
+10.79%
